Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Pharmacogenetics and Genomics|September 22, 2007
Interaction between beta2 adrenergic receptor polymorphisms determines the extent of isoproterenol-induced vasodilatation ex vivoJawad M Khalaila, Amir Elami, Yoseph Caraco
Pharmacotherapy|January 17, 2002
Major bleeding caused by warfarin in a genetically susceptible patientAharon Bloch, Eldad Ben-Chetrit, Mordechai Muszkat, et al.
European Journal of Clinical Pharmacology|November 11, 2011
Factor VII R353Q genetic polymorphism is associated with altered warfarin sensitivity among CYP2C9 *1/*1 carriersLiat Mlynarsky, Idit Bejarano-Achache, Mordechai Muszkat, et al.
Frontiers in Pharmacology|October 19, 2020
Comparison of CYP2C9 Activity in Ethiopian and Non-Ethiopian Jews Using Phenytoin as a ProbeZahi Abu Ghosh, Shoshana Alamia, Chanan Shaul, et al.
Pharmacogenetics and Genomics|August 28, 2015
Effects of sex and the common ADRB1 389 genetic polymorphism on the hemodynamic response to dobutamineDotan Yogev, Maamoun Basheer, Simcha Blotnick, et al.
European Journal of Clinical Pharmacology|November 10, 2018
The impact of R353Q genetic polymorphism in coagulation factor VII on the initial anticoagulant effect exerted by warfarinChanan Shaul, Simcha Blotnick, Liat Deutsch, et al.
Clinical Therapeutics|June 20, 2007
Warfarin metabolism and anticoagulant effect: a prospective, observational study of the impact of CYP2C9 genetic polymorphism in the presence of drug-disease and drug-drug interactionsMordechai Muszkat, Simcha Blotnik, Amir Elami, et al.
Molecular Diagnosis & Therapy|November 24, 2016
Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy SubjectsChanan Shaul, Simcha Blotnick, Mordechai Muszkat, et al.
The Annals of Pharmacotherapy|May 4, 2006
Clozapine-induced systemic lupus erythematosusAbu Fanne Rami, Daniel Barkan, Dror Mevorach, et al.
Clinical Pharmacokinetics|July 27, 2022
Clinically Relevant Interactions Between Ritonavir-Boosted Nirmatrelvir and Concomitant Antiseizure Medications: Implications for the Management of COVID-19 in Patients with EpilepsyMaor Wanounou, Yoseph Caraco, René H Levy, et al.
Pageof 5